You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Acalabrutinib

Showing 51 - 75 of 137
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Duarte (Acalabrutinib,

Recruiting
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Acalabrutinib
  • CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Jun 16, 2022

Chronic Lymphoid Leukemia Trial in Germany (Bendamustine, Obinutuzumab, Acalabrutinib)

Active, not recruiting
  • Chronic Lymphoid Leukemia
  • Dresden, Germany
  • +16 more
Nov 8, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (Acalabrutinib, Obinutuzumab)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Basking Ridge, New Jersey
  • +7 more
Nov 9, 2022

Diffuse Large B Cell Lymphoma Trial in Colchester, Canterbury, Nottingham (R-CHOP, R-CHOP + acalabrutinib)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Colchester, Essex, United Kingdom
  • +32 more
Oct 25, 2022

Activated B-cell DLBCL (ABC DLBCL) Trial in United Kingdom, United States (Acalabrutinib)

Active, not recruiting
Has Results
  • Activated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL)
  • Acalabrutinib
  • Los Angeles, California
  • +6 more
Dec 1, 2022

Chronic Lymphocytic Leukemia Trial (Loncastuximab Tesirine)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Loncastuximab Tesirine
  • (no location specified)
Jul 24, 2023

Phase I: Relapsed or Refractory B-cell Malignancies, Phase II Cohort A: Relapsed or Refractory Mantle Cell Lymphoma, Phase II

Active, not recruiting
  • Phase I: Relapsed or Refractory B-cell Malignancies
  • +2 more
  • Acalabrutinib
  • Beijing, China
  • +22 more
Dec 8, 2022

ALICIA (Acalabrutinib in CLL Therapy)

Recruiting
  • Chronic Lymphocytic Leukemia
    • Irkutsk, Russian Federation
    • +12 more
    Jul 27, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia Trial in Columbus (acalabrutinib,

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +2 more
    • acalabrutinib
    • +3 more
    • Columbus, Ohio
      Research Site
    Mar 11, 2022

    COVID-19 Trial in Porto Alegre, Ribeirão Preto, Sao Paulo (Acalabrutinib)

    Terminated
    Has Results
    • COVID-19
    • Acalabrutinib
    • Porto Alegre, Brazil
    • +3 more
    Nov 16, 2021

    Mantle Cell Lymphoma Trial in New York (Acalabrutinib, Lenalidomide, Rituximab)

    Recruiting
    • Mantle Cell Lymphoma
    • Acalabrutinib
    • +2 more
    • New York, New York
      Weill Cornell Medicine
    Oct 29, 2021

    Healthy Volunteers Trial in Tempe (Acalabrutinib, Fluconazole, Isavuconazole)

    Completed
    • Healthy Volunteers
    • Acalabrutinib
    • +2 more
    • Tempe, Arizona
      Celerion
    Nov 17, 2021

    Chronic Lymphocytic Leukemia Trial in Columbus, Hermitage, Fort Worth (acalabrutinib, ACP-319)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Columbus, Ohio
    • +1 more
    Jan 20, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome Trial in Italy, United Kingdom, United States

    Active, not recruiting
    Has Results
    • Chronic Lymphocytic Leukemia
    • +3 more
    • Acalabrutinib
    • Boston, Massachusetts
    • +11 more
    Nov 23, 2022

    CLL/SLL Trial in Belgium, Denmark, Netherlands (Venetoclax/Acalabrutinib)

    Recruiting
    • CLL/SLL
    • Brussels, Belgium
    • +17 more
    Mar 22, 2022

    Chronic Lymphoid Leukemia Trial in Austria, Germany (Acalabrutinib)

    Recruiting
    • Chronic Lymphoid Leukemia
    • Acalabrutinib
    • Innsbruck, Austria
    • +19 more
    Mar 21, 2022

    Hepatic Impairment, Hepatic Insufficiency, Healthy Subjects Trial in Miami, Orlando, Knoxville (acalabrutinib)

    Completed
    Has Results
    • Hepatic Impairment
    • +2 more
    • acalabrutinib
    • Miami, Florida
    • +2 more
    Aug 16, 2021

    Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma Trial in Atlanta (drug, biological,

    Recruiting
    • Grade 1 Follicular Lymphoma
    • +7 more
    • Acalabrutinib
    • +3 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Dec 7, 2021

    Part1: Advanced B-cell Malignancies, Part2: r/rCLL and r/rMCL, Part3: Untreated CLL Trial in Japan (Acalabrutinib, Obinutuzumab)

    Active, not recruiting
    • Part1: Advanced B-cell Malignancies
    • +2 more
    • Chiba-shi, Japan
    • +13 more
    Jan 31, 2022

    Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Trial in Worldwide (Acalabrutinib, Venetoclax, Obinutuzumab)

    Recruiting
    • Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    • Acalabrutinib
    • +2 more
    • Tucson, Arizona
    • +40 more
    Dec 20, 2022

    Chronic Lymphocytic Leukemia, Chronic Graft-versus-host-disease, Mantle Cell Lymphoma Trial in Poland (Acalabrutinib 2x100 MG

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +4 more
    • Acalabrutinib 2x100 MG Oral Capsule + alloSCT
    • Warszawa, Mazowieckie, Poland
    • +5 more
    Dec 23, 2021

    Untreated Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib, Rituximab, Chlorambucil)

    Recruiting
    • Untreated Chronic Lymphocytic Leukemia
    • Acalabrutinib
    • +2 more
    • Beijing, China
    • +50 more
    Sep 26, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Acalabrutinib)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Boston, Massachusetts
    • +2 more
    Aug 9, 2021

    MCL, Mantle Cell Lymphoma Trial in Worldwide (Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma)

    Recruiting
    • MCL
    • Mantle Cell Lymphoma
    • Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma
    • Odense, Denmark
    • +21 more
    Feb 11, 2022

    Healthy Volunteers Trial in Tempe (Acalabrutinib, SmartPill®)

    Completed
    • Healthy Volunteers
    • Tempe, Arizona
      Celerion
    Jun 2, 2021